Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis
- 30 September 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 70 (3) , 398-403
- https://doi.org/10.1006/gyno.1998.5125
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Social controls on cell survival and cell deathNature, 1992
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985